GSA CAPITAL PARTNERS LLP - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 80 filers reported holding CYTOSORBENTS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q1 2022$420,000
+677.8%
131,655
+912.5%
0.06%
+700.0%
Q4 2021$54,000
-90.8%
13,003
-82.9%
0.01%
-95.2%
Q1 2020$586,000
+134.4%
75,869
+16.8%
0.15%
+406.9%
Q4 2019$250,000
+51.5%
64,970
+98.0%
0.03%
+31.8%
Q3 2019$165,000
+28.9%
32,820
+94.4%
0.02%
+69.2%
Q1 2019$128,00016,8820.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders